相似文献
1
Psychotropic and pain medication use in nursing homes and assisted living facilities during COVID-19.
J Am Geriatr Soc. 2022 May;70(5):1345-1348. doi: 10.1111/jgs.17739. Epub 2022 Mar 6.
2
Eight-Year Trends in the Use of Opioids, Other Analgesics, and Psychotropic Medications Among Institutionalized Older People in Finland.
J Am Med Dir Assoc. 2015 Nov 1;16(11):973-8. doi: 10.1016/j.jamda.2015.06.009. Epub 2015 Jul 10.
3
Can a Nursing Home Psychotropic Reduction Project be Successfully Implemented in Assisted Living?
J Appl Gerontol. 2021 Sep;40(9):1071-1079. doi: 10.1177/0733464820948328. Epub 2020 Aug 8.
4
Assessment of Psychotropic Drug Prescribing Among Nursing Home Residents in Ontario, Canada, During the COVID-19 Pandemic.
JAMA Intern Med. 2021 Jun 1;181(6):861-863. doi: 10.1001/jamainternmed.2021.0224.
5
Perceived anxiety, depression, and sleeping problems in relation to psychotropic drug use among elderly in assisted-living facilities.
Eur J Clin Pharmacol. 2005 May;61(3):215-24. doi: 10.1007/s00228-004-0857-6. Epub 2005 Mar 11.
6
Care-Delivery Interventions to Manage Agitation and Aggression in Dementia Nursing Home and Assisted Living Residents: A Systematic Review and Meta-analysis.
J Am Geriatr Soc. 2016 Mar;64(3):477-88. doi: 10.1111/jgs.13936.
7
[Well-Being in old age – content validity of the Ryff Scale for residents of nursing homes and assisted living facilities].
Pflege. 2016;29(3):137-49. doi: 10.1024/1012-5302/a000485.
8
Living Arrangements of Older Adults and COVID-19 Risk: It Is Not Just Nursing Homes.
J Am Geriatr Soc. 2020 Jul;68(7):1398-1399. doi: 10.1111/jgs.16529. Epub 2020 May 26.
9
Psychotropic use in community residential care facilities: A prospective cohort study.
Am J Geriatr Pharmacother. 2006 Sep;4(3):227-35. doi: 10.1016/j.amjopharm.2006.09.010.
10
[Comparison of health conservation for elders in assisted living facilities and nursing homes].
Taehan Kanho Hakhoe Chi. 2005 Dec;35(7):1379-89. doi: 10.4040/jkan.2005.35.7.1379.
引用本文的文献
1
Machine learning-driven identification of key risk factors for predicting depression among nurses.
BMC Nurs. 2025 Apr 3;24(1):368. doi: 10.1186/s12912-025-02957-6.
2
Consequences of contact restrictions for long-term care residents during the first months of COVID-19 pandemic: a scoping review.
Eur J Ageing. 2023 Oct 17;20(1):39. doi: 10.1007/s10433-023-00787-6.
3
Prescriptions of antipsychotics dispensed in long-term care facilities during the COVID-19 pandemic.
Gen Hosp Psychiatry. 2022 Sep-Oct;78:141-142. doi: 10.1016/j.genhosppsych.2022.05.010. Epub 2022 May 27.
本文引用的文献
1
Trends in Post-Acute Care Utilization During the COVID-19 Pandemic.
J Am Med Dir Assoc. 2021 Dec;22(12):2496-2499. doi: 10.1016/j.jamda.2021.09.001. Epub 2021 Sep 7.
2
Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada.
JAMA Netw Open. 2021 Aug 2;4(8):e2118441. doi: 10.1001/jamanetworkopen.2021.18441.
3
Managing Pain and Psychosis Symptoms in Nursing Home Patients: Results from a Cluster-Randomized Controlled Trial (COSMOS).
J Am Med Dir Assoc. 2021 Aug;22(8):1692-1698. doi: 10.1016/j.jamda.2021.05.008. Epub 2021 Jun 2.
4
Assessment of Psychotropic Drug Prescribing Among Nursing Home Residents in Ontario, Canada, During the COVID-19 Pandemic.
JAMA Intern Med. 2021 Jun 1;181(6):861-863. doi: 10.1001/jamainternmed.2021.0224.
5
Nursing home oversight during the COVID-19 pandemic.
J Am Geriatr Soc. 2021 Apr;69(4):850-860. doi: 10.1111/jgs.17047. Epub 2021 Feb 12.
6
Challenge of changing nursing home prescribing culture.
Am J Geriatr Pharmacother. 2012 Feb;10(1):37-46. doi: 10.1016/j.amjopharm.2011.12.005. Epub 2012 Jan 20.
7
Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey.
Am J Geriatr Psychiatry. 2010 Dec;18(12):1078-92. doi: 10.1097/JGP.0b013e3181d6c0c6.
8
The quality of antipsychotic drug prescribing in nursing homes.
Arch Intern Med. 2005 Jun 13;165(11):1280-5. doi: 10.1001/archinte.165.11.1280.
Zotero 插件